BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs. 2017

Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012, Jinan, Shandong, PR China.

As a continuation of our efforts to discover and develop "me-better" drugs of DAPYs, novel diarylpyridine derivatives were designed, synthesized and evaluated for their anti-HIV activities in MT-4 cells. The majority of these compounds showed high activity against wild-type HIV-1 strain (IIIB) with EC50 values in the range of 0.04-4.41 μM. Among them, compound 5b2 (EC50 = 0.04 μM, SI = 3963) was the most potent. This compound showed anti-HIV-1IIIB activity superior than of Nevirapine but still inferior than of Etravirine. Selected compounds were also evaluated for the activity against reverse transcriptase (RT), and most of the compounds exhibited submicromolar IC50 values indicating they are specific RT inhibitors. Preliminary structure-activity relationships and modeling studies of these new analogues provide valuable avenues for future molecular optimization.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass
D066241 Carbon-13 Magnetic Resonance Spectroscopy Magnetic resonance spectroscopy involving detection of changes in the resonance of carbon-13 nuclei in organic molecules. 13C NMR,Carbon 13 Magnetic Resonance Spectroscopy

Related Publications

Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
June 2021, Bioorganic & medicinal chemistry,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.
April 2013, Bioorganic & medicinal chemistry,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors.
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
February 2016, European journal of medicinal chemistry,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation.
November 2023, European journal of medicinal chemistry,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Design and synthesis of Fsp3-enriched spirocyclic-substituted diarylpyrimidine derivatives as novel HIV-1 NNRTIs.
March 2024, Chemical biology & drug design,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419.
January 2015, Expert opinion on therapeutic patents,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs.
January 2014, Bioorganic & medicinal chemistry,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
Novel indole sulfides as potent HIV-1 NNRTIs.
March 2016, Bioorganic & medicinal chemistry letters,
Zhaoqiang Liu, and Ye Tian, and Jinghan Liu, and Boshi Huang, and Dongwei Kang, and Erik De Clercq, and Dirk Daelemans, and Christophe Pannecouque, and Peng Zhan, and Xinyong Liu
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies.
April 2021, Journal of medicinal chemistry,
Copied contents to your clipboard!